BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34176089)

  • 21. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
    Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
    Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical value of lymph node dissection of No. 14cd during pancreaticoduodenectomy in patients with pancreatic head carcinoma].
    Wu PF; Zhang K; Tian L; Yin J; Wei JS; Xi CH; Chen JM; Guo F; Lu ZP; Miao Y; Jiang KR
    Zhonghua Wai Ke Za Zhi; 2023 Jul; 61(7):582-589. PubMed ID: 37402687
    [No Abstract]   [Full Text] [Related]  

  • 23. Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?
    Fang HA; Irfan A; Vickers SM; Gbolahan O; Williams GR; Outlaw D; Wang TN; Dudeja V; Rose JB; Reddy S
    J Surg Res; 2023 Apr; 284():143-150. PubMed ID: 36571869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
    Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
    J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.
    Basturk O; Saka B; Balci S; Postlewait LM; Knight J; Goodman M; Kooby D; Sarmiento JM; El-Rayes B; Choi H; Bagci P; Krasinskas A; Quigley B; Reid MD; Akkas G; Maithel SK; Adsay V
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1187-95. PubMed ID: 26362048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer.
    Hoshikawa M; Ogata S; Nishikawa M; Kimura A; Einama T; Noro T; Aosasa S; Hase K; Tsujimoto H; Ueno H; Yamamoto J
    Medicine (Baltimore); 2019 Feb; 98(5):e14369. PubMed ID: 30702628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discordance Between Conventional and Detailed Lymph Node Analysis in Resected, Node-negative Pancreatic or Ampullary Adenocarcinomas and Association With Adverse Survival Outcomes: A Single-institution Analysis.
    Elshami M; Ammoun AK; Mneimneh WS; Stitzel HJ; Hue JJ; Wu VS; Kyasaram RK; Shanahan J; Musonza T; Ammori JB; Hardacre JM; Winter JM; ElHag M; Ocuin LM
    Ann Surg; 2023 Dec; 278(6):e1204-e1209. PubMed ID: 37051926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment.
    You MS; Lee SH; Choi YH; Shin BS; Paik WH; Ryu JK; Kim YT; Jang DK; Lee JK; Kwon W; Jang JY; Kim SW
    BMC Cancer; 2019 Oct; 19(1):952. PubMed ID: 31615457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
    La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
    Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An interactive Bayesian model for prediction of lymph node ratio and survival in pancreatic cancer patients.
    Smith BJ; Mezhir JJ
    J Am Med Inform Assoc; 2014 Oct; 21(e2):e203-11. PubMed ID: 24444460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma.
    Fukuda Y; Asaoka T; Maeda S; Hama N; Miyamoto A; Mori M; Doki Y; Nakamori S
    Pancreatology; 2017; 17(2):279-284. PubMed ID: 28122676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
    Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.